Angiotensin II activates MCP-1 through the infiltration of monocytes and macrophages into the heart and induces cardiac hypertrophy and dysfunction via Toll-like receptor 4

被引：0
|
作者：
Umemoto, S. [1 ]
Matsuda, S. [2 ]
Yoshimura, K. [3 ]
Murata, T. [4 ]
Fukai, T. [5 ]
Matsuzak, M. [2 ]
机构：
[1] Yamaguchi Univ, Clin Res Ctr, Ube, Yamaguchi, Japan
[2] Yamaguchi Univ, Grad Sch Med, Dept Med & Clin Sci, Ube, Yamaguchi 755, Japan
[3] Yamaguchi Univ, Grad Sch Med, Dept Surg & Clin Sci, Ube, Yamaguchi 755, Japan
[4] Yamaguchi Univ, Inst Expt Anim, Ctr Sci Res, Ube, Yamaguchi 755, Japan
[5] Univ Illinois, Dept Pharmacol, Chicago, IL USA
来源：
EUROPEAN HEART JOURNAL | 2015年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P4732
引用
收藏
页码：832 / 832
页数：1
相关论文
共 50 条
  • [31] From Skeleton to Cytoskeleton Osteocalcin Transforms Vascular Fibroblasts to Myofibroblasts Via Angiotensin II and Toll-Like Receptor 4
    Yuen, Chi Yung
    Wong, Siu Ling
    Lau, Chi Wai
    Tsang, Suk-Ying
    Xu, Aimin
    Zhu, Zhiming
    Ng, Chi Fai
    Yao, Xiaoqiang
    Kong, Siu Kai
    Lee, Hung Kay
    Huang, Yu
    CIRCULATION RESEARCH, 2012, 111 (03) : E55 - E66
  • [32] Bacterial lipopolysaccharide enhances cardiac dysfunction but not retroviral replication in murine AIDS - Roles of macrophage infiltration and toll-like receptor 4 expression
    Chaves, AA
    Baliga, RS
    Mihm, MJ
    Schanbacher, BL
    Basuray, A
    Liu, C
    Cook, AC
    Ayers, LW
    Bauer, JA
    AMERICAN JOURNAL OF PATHOLOGY, 2006, 168 (03): : 727 - 736
  • [33] Dengue virus nonstructural protein 1 activates platelets via Toll-like receptor 4, leading to thrombocytopenia and hemorrhage
    Chao, Chiao-Hsuan
    Wu, Wei-Chueh
    Lai, Yen-Chung
    Tsai, Pei-Jane
    Perng, Guey-Chuen
    Lin, Yee-Shin
    Yeh, Trai-Ming
    PLOS PATHOGENS, 2019, 15 (04)
  • [34] Epac1 Protects Heart From Lipopolysaccharide-induced Cardiac Dysfunction by Inhibiting the Toll-like Receptor 4 Signaling Pathway
    Okumura, Satoshi
    Jin, Meihua
    Bai, Yunzhe
    Suzuki, Sayaka
    Xuan, Xuezhe
    Cai, Wenqian
    Hidaka, Yuko
    Kurotani, Reiko
    Yokoyama, Utako
    Ishikawa, Yoshihiro
    CIRCULATION, 2009, 120 (18) : S841 - S842
  • [35] Myocardial Ischemia Activates an Injurious Innate Immune Signaling via Cardiac Heat Shock Protein 60 and Toll-like Receptor 4
    Li, Yan
    Si, Rui
    Feng, Yan
    Chen, Howard H.
    Zou, Lin
    Wang, E.
    Zhang, Ming
    Warren, H. Shaw
    Sosnovik, David E.
    Chao, Wei
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (36) : 31308 - 31319
  • [36] Brain AT1 Receptor Activates the Sympathetic Nervous System Through Toll-like Receptor 4 in Mice With Heart Failure (vol 58, pg 543, 2011)
    Ogawa, K.
    Hirooka, Y.
    Kishi, T.
    Sunagawa, K.
    Brain, A. T.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2012, 59 (02) : 206 - 206
  • [37] Excess Glucose Induces Trophoblast Inflammation Through HMGB1 Activation of Toll-Like Receptor 4.
    Heim, Kathleen R.
    Potter, Julie A.
    Han, Christina S.
    Abrahams, Vikki M.
    REPRODUCTIVE SCIENCES, 2017, 24 : 164A - 164A
  • [38] Angiotensin II leads only to left ventricular remodelling and heart failure in the presence of Toll-like receptor 4 signalling in vivo and in vitro
    Riad, A.
    Savvatis, K.
    Zietsch, C.
    Becher, P. M.
    Lindner, D.
    Westermann, D.
    Schultheiss, H. P.
    EUROPEAN HEART JOURNAL, 2010, 31 : 420 - 421
  • [39] Mechanical stress-evoked but angiotensin II-independent activation of angiotensin II type 1 receptor induces cardiac hypertrophy through calcineurin pathway
    Zhou, Ning
    Li, Lei
    Wu, Jian
    Gong, Hui
    Niu, Yuhong
    Sun, Aijun
    Ge, Junbo
    Zou, Yunzeng
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 397 (02) : 263 - 269
  • [40] Inhibition of STAT3 activation mediated by toll-like receptor 4 attenuates angiotensin II-induced renal fibrosis and dysfunction
    Xu, Zheng
    Zou, Chunpeng
    Yu, Weihui
    Xu, Sujing
    Huang, Lan
    Khan, Zia
    Wang, Jingying
    Liang, Guang
    Wang, Yi
    BRITISH JOURNAL OF PHARMACOLOGY, 2019, 176 (14) : 2627 - 2641
12345